Haemonetics Corporation (HAE) is a Healthcare · Medical Devices company listed on NYSE. Price $108.40 (+0.74%), Market cap $2.71B, P/E ratio 29.05, 52-week low–high $47.67 ~ $87.16.
Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 tools. It also provides treatment in electrophysiology, critical care, neurocritical care, trauma, burn surgery, spine surgery, and cancer surgery; SavvyWir
Financial statements, price targets, institutional (13F) holdings and related news for Haemonetics Corporation are updated in real time on BlackAll Trade.
Haemonetics Corporation trades at $108.40 (+0.74%). Real-time quotes and charts are available on BlackAll Trade.
Haemonetics Corporation has a market cap of about $2.71B. Its P/E ratio is 29.05.
Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions in the United States and internationally. The company offers automated plasma collection syst